Akron’s innovative design can help improve your cell & gene therapy manufacturing process
Expect more out of your pDNA service provider. At Akron Bio, we manufacture a robust product with high yields and unmatched purity.
Akron’s high-quality cGMP Recombinant Proteins offer the consistency, safety, and efficacy that empower today’s leading clinical and commercial cell therapy companies.
Akron’s proven blood products deliver safety and performance backed by robust and redundant supply. Because you can’t afford to compromise.
Capitalizing on our established platform for manufacturing cGMP-compliant, clinical-grade ancillary products, Akron is well-positioned to provide custom development and manufacturing to accelerate the commercialization of advanced therapies.
At Akron, we manufacture high-quality compliant cGMP plasmid DNA for pre-clinical, clinical, and commercial gene therapy and vaccine companies where material needs are 1+ grams.
Miami Beach, FL
We are thrilled to be a gold sponsor & exhibitor at Advanced Therapies Week. Please join us at our booth, #313 to meet our team and learn more about Akron Bio's product line.
We are excited to be attending this year's Allogeneic Cell Therapies Summit in London.
San Francisco, CA
Akron Bio is proud to be a sponsoring partner & roundtable facilitator at this year's US West Coast Advanced Therapies Xchange. Register today!
Akron Bio's Business Development Director Sara Padrell will be presenting at the CAR-TCR Summit on how to Build a Commercial-Ready Cell & Gene Therapy Supply Chain. Register today to listen to her speak!
Apr 14, 2022
Akron BioProducts Announces Launch of its Closed System Solutions™ line to Enable Seamless Integration of cGMP Ancillary Materials in Cell and Gene Therapy Manufacturing
Apr 12, 2022
Akron Bio Expands Commercialization of Advanced Gene Therapy and Vaccine Production with New Manufacturing Facility